We analyzed the anti-oncogenic effects of 5α-reductase inhibition on tumor progression in both control BCa cells and AR-overexpressing cells by measuring proliferation, migration, and the expression levels of cancer-related signaling pathways and target genes. This evidence concerns the gene AR and cancer.